name,category,termsAHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast),INTERPRO[450013752$IPR015310:Activator of Hsp90 ATPase, N-terminal]
AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000288$Chaperone, 790000356$complete proteome, 790001212$polymorphism, 790001450$stress response]
AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast),UP_SEQ_FEATURE[850003671$chain:Activator of 90 kDa heat shock protein ATPase homolog 2, 850117295$sequence variant, 850118574$splice variant]
ATM interactor,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like]
ATM interactor,SMART[760000323$SM00355:ZnF_C2H2]
ATM interactor,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
ATM interactor,UP_SEQ_FEATURE[850006416$chain:ATM interactor, 850102378$compositionally biased region:Ala-rich, 850114302$region of interest:Required for formation of RAD51 foci, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118709$zinc finger region:C2H2-type 2; degenerate]
ATPase, (Na+)/K+ transporting, beta 4 polypeptide,INTERPRO[450000345$IPR000402:ATPase, P-type cation exchange, beta subunit]
ATPase, (Na+)/K+ transporting, beta 4 polypeptide,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction, 470038890$hsa04960:Aldosterone-regulated sodium reabsorption]
ATPase, (Na+)/K+ transporting, beta 4 polypeptide,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000739$Hydrogen ion transport, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane, 790001558$transport]
ATPase, (Na+)/K+ transporting, beta 4 polypeptide,UP_SEQ_FEATURE[850100985$chain:X/potassium-transporting ATPase subunit beta-m, 850102507$compositionally biased region:Glu-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ATPase, Ca++ transporting, type 2C, member 1,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005835$IPR006413:ATPase, P-type, calcium-transporting, PMR1-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, type 2C, member 1,OMIM_DISEASE[520000549$benign chronic pemphigus (Hailey-Hailey disease), 520002207$Hailey-Hailey disease]
ATPase, Ca++ transporting, type 2C, member 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, type 2C, member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000624$golgi apparatus, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, type 2C, member 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850009067$chain:Calcium-transporting ATPase type 2C member 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2,INTERPRO[450004593$IPR005124:Vacuolar (H+)-ATPase G subunit]
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2,PIR_SUPERFAMILY[630005500$PIRSF005577:V-type ATPase, subunit G]
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000739$Hydrogen ion transport, 790000798$ion transport, 790001558$transport]
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2,UP_SEQ_FEATURE[850099816$chain:V-type proton ATPase subunit G 2]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,INTERPRO[450005225$IPR005772:ATPase, V1 complex, subunit F, eukaryotic, 450007526$IPR008218:ATPase, V1/A1 complex, subunit F]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,PIR_SUPERFAMILY[630012715$PIRSF015945:ATPase_V1_F_euk, 630012716$PIRSF015945:V-type ATPase, subunit F]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,SP_PIR_KEYWORDS[790000356$complete proteome, 790000739$Hydrogen ion transport, 790000798$ion transport, 790001212$polymorphism, 790001558$transport]
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F,UP_SEQ_FEATURE[850099812$chain:V-type proton ATPase subunit F, 850117294$sequence conflict, 850117295$sequence variant]
ATR interacting protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000452$DNA damage, 790000459$dna repair, 790000811$isopeptide bond, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
ATR interacting protein,UP_SEQ_FEATURE[850006800$chain:ATR-interacting protein, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850106259$mutagenesis site, 850112197$region of interest:Interaction with CINP, 850117294$sequence conflict, 850117295$sequence variant, 850117440$short sequence motif:EEXXXDL motif, 850118574$splice variant]
BCL2-antagonist/killer 1; BCL2-like 7 pseudogene 1,BIOCARTA[30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling]
BCL2-antagonist/killer 1; BCL2-like 7 pseudogene 1,INTERPRO[450000611$IPR000712:Apoptosis regulator Bcl-2, BH, 450002195$IPR002475:BCL2-like apoptosis inhibitor]
BCL2-antagonist/killer 1; BCL2-like 7 pseudogene 1,PIR_SUPERFAMILY[630030278$PIRSF038829:Bcl2 homologous antagonist/killer]
BCL2-antagonist/killer 1; BCL2-like 7 pseudogene 1,SMART[760000305$SM00337:BCL]
BCL2-antagonist/killer 1; BCL2-like 7 pseudogene 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000109$Apoptosis, 790000356$complete proteome, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001555$transmembrane, 790001648$zinc]
BCL2-antagonist/killer 1; BCL2-like 7 pseudogene 1,UP_SEQ_FEATURE[850007408$chain:Bcl-2 homologous antagonist/killer, 850049887$chain:Putative Bcl-2 homologous antagonist/killer 2, 850105852$helix, 850106248$metal ion-binding site:Zinc; shared with dimeric partner, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117317$short sequence motif:BH1, 850117318$short sequence motif:BH2, 850117319$short sequence motif:BH3, 850118623$transmembrane region, 850118624$turn]
BCL2/adenovirus E1B 19kDa interacting protein 1,INTERPRO[450005055$IPR005606:Sec20]
BCL2/adenovirus E1B 19kDa interacting protein 1,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
BCL2/adenovirus E1B 19kDa interacting protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
BCL2/adenovirus E1B 19kDa interacting protein 1,UP_SEQ_FEATURE[850100220$chain:Vesicle transport protein SEC20, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
C-type lectin domain family 17, member A,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 17, member A,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 17, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000848$Lectin, 790000919$membrane, 790001555$transmembrane]
C-type lectin domain family 17, member A,UP_SEQ_FEATURE[850008692$chain:C-type lectin and transmembrane domain- containing protein FLJ45910, 850103184$domain:C-type lectin, 850118623$transmembrane region]
CDC42 small effector 2,INTERPRO[450000079$IPR000095:PAK-box/P21-Rho-binding]
CDC42 small effector 2,SMART[760000256$SM00285:PBD]
CDC42 small effector 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001136$phagocytosis]
CDC42 small effector 2,UP_SEQ_FEATURE[850010191$chain:CDC42 small effector protein 2, 850102566$compositionally biased region:Poly-Arg, 850103411$domain:CRIB, 850105898$lipid moiety-binding region:S-palmitoyl cysteine]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked,KEGG_PATHWAY[470038864$hsa04622:RIG-I-like receptor signaling pathway]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked,PIR_SUPERFAMILY[630001466$PIRSF001321:ATP-dependent RNA helicase]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790000649$helicase, 790000733$host-virus interaction, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked,UP_SEQ_FEATURE[850006698$chain:ATP-dependent RNA helicase DDX3X, 850102534$compositionally biased region:Gly/Ser-rich, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850113656$region of interest:Necessary for interaction with XPO1, 850117294$sequence conflict, 850117295$sequence variant, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif, 850118575$strand]
DENN/MADD domain containing 4C,INTERPRO[450001049$IPR001194:DENN, 450002551$IPR002885:Pentatricopeptide repeat, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 4C,SMART[760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 4C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
DENN/MADD domain containing 4C,UP_SEQ_FEATURE[850014833$chain:DENN domain-containing protein 4C, 850102581$compositionally biased region:Poly-Ser, 850103503$domain:dDENN, 850103514$domain:DENN, 850105606$domain:uDENN, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116805$repeat:PPR, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
DEP domain containing 1B,INTERPRO[450000169$IPR000198:RhoGAP, 450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450010816$IPR011991:Winged helix repressor DNA-binding]
DEP domain containing 1B,SMART[760000041$SM00049:DEP, 760000293$SM00324:RhoGAP]
DEP domain containing 1B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790001212$polymorphism]
DEP domain containing 1B,UP_SEQ_FEATURE[850014891$chain:DEP domain-containing protein 1B, 850102577$compositionally biased region:Poly-Lys, 850103515$domain:DEP, 850105183$domain:Rho-GAP, 850117294$sequence conflict, 850117295$sequence variant]
DnaJ (Hsp40) homolog, subfamily C, member 4,INTERPRO[450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450002720$IPR003095:Heat shock protein DnaJ, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
DnaJ (Hsp40) homolog, subfamily C, member 4,SMART[760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily C, member 4,SP_PIR_KEYWORDS[790000288$Chaperone, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
DnaJ (Hsp40) homolog, subfamily C, member 4,UP_SEQ_FEATURE[850016181$chain:DnaJ homolog subfamily C member 4, 850104487$domain:J, 850118623$transmembrane region]
EBNA1 binding protein 2,INTERPRO[450007870$IPR008610:Eukaryotic rRNA processing]
EBNA1 binding protein 2,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001331$ribosome biogenesis]
EBNA1 binding protein 2,UP_SEQ_FEATURE[850043664$chain:Probable rRNA-processing protein EBP2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
G protein regulated inducer of neurite outgrowth 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000267$cell projection, 790000356$complete proteome, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism]
G protein regulated inducer of neurite outgrowth 1,UP_SEQ_FEATURE[850020258$chain:G protein-regulated inducer of neurite outgrowth 1, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850112370$region of interest:Interaction with GNAO1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
G protein-coupled receptor 17,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450002032$IPR002286:P2 purinoceptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 17,PIR_SUPERFAMILY[630030123$PIRSF038619:uracil nucleotide/cysteinyl leukotriene receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 17,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 17,UP_SEQ_FEATURE[850099571$chain:Uracil nucleotide/cysteinyl leukotriene receptor, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
GRB2-associated binding protein 3,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
GRB2-associated binding protein 3,SMART[760000205$SM00233:PH]
GRB2-associated binding protein 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
GRB2-associated binding protein 3,UP_SEQ_FEATURE[850022391$chain:GRB2-associated-binding protein 3, 850104979$domain:PH, 850117295$sequence variant]
GTPase, IMAP family member 2,INTERPRO[450006113$IPR006703:AIG1]
GTPase, IMAP family member 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000639$gtp-binding, 790000919$membrane, 790001063$nucleotide-binding, 790001212$polymorphism, 790001555$transmembrane]
GTPase, IMAP family member 2,UP_SEQ_FEATURE[850022634$chain:GTPase IMAP family member 2, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant, 850118623$transmembrane region]
IQ motif and Sec7 domain 2,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450000787$IPR000904:SEC7-like, 450001635$IPR001849:Pleckstrin homology]
IQ motif and Sec7 domain 2,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
IQ motif and Sec7 domain 2,SMART[760000009$SM00015:IQ, 760000194$SM00222:Sec7, 760000205$SM00233:PH]
IQ motif and Sec7 domain 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein]
IQ motif and Sec7 domain 2,UP_SEQ_FEATURE[850026751$chain:IQ motif and SEC7 domain-containing protein 2, 850102540$compositionally biased region:His-rich, 850102572$compositionally biased region:Poly-Glu, 850102586$compositionally biased region:Pro-rich, 850104439$domain:IQ, 850104979$domain:PH, 850105336$domain:SEC7, 850106258$modified residue, 850118574$splice variant]
Josephin domain containing 1,INTERPRO[450005587$IPR006155:Machado-Joseph disease protein MJD]
Josephin domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
Josephin domain containing 1,UP_SEQ_FEATURE[850026972$chain:Josephin-1, 850104490$domain:Josephin, 850117295$sequence variant]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2,INTERPRO[450000112$IPR000133:ER lumen protein retaining receptor]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2,KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000510$er-golgi transport, 790000919$membrane, 790001266$protein transport, 790001301$receptor, 790001555$transmembrane, 790001558$transport]
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2,UP_SEQ_FEATURE[850017753$chain:ER lumen protein retaining receptor 2, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
KIAA1530,INTERPRO[450016882$IPR018610:Protein of unknown function DUF2043]
KIAA1530,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA1530,UP_SEQ_FEATURE[850075552$chain:Uncharacterized protein KIAA1530, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
KIAA1683,COG_ONTOLOGY[90000053$Cytoskeleton]
KIAA1683,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region]
KIAA1683,SMART[760000009$SM00015:IQ]
KIAA1683,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
KIAA1683,UP_SEQ_FEATURE[850075562$chain:Uncharacterized protein KIAA1683, 850102605$compositionally biased region:Thr-rich, 850104440$domain:IQ 1, 850104451$domain:IQ 2, 850104462$domain:IQ 3, 850104473$domain:IQ 4, 850104477$domain:IQ 5, 850104478$domain:IQ 6, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
Kruppel-like factor 2 (lung),COG_ONTOLOGY[90000073$General function prediction only]
Kruppel-like factor 2 (lung),INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
Kruppel-like factor 2 (lung),SMART[760000323$SM00355:ZnF_C2H2]
Kruppel-like factor 2 (lung),SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
Kruppel-like factor 2 (lung),UP_SEQ_FEATURE[850027607$chain:Krueppel-like factor 2, 850102565$compositionally biased region:Poly-Ala, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
MAS-related GPR, member D,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
MAS-related GPR, member D,PIR_SUPERFAMILY[630001858$PIRSF001712:mas-related G protein-coupled receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
MAS-related GPR, member D,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
MAS-related GPR, member D,UP_SEQ_FEATURE[850030539$chain:Mas-related G-protein coupled receptor member D, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
MORN repeat containing 3,COG_ONTOLOGY[90000070$Function unknown]
MORN repeat containing 3,INTERPRO[450002977$IPR003409:MORN motif]
MORN repeat containing 3,SMART[760000606$SM00698:MORN]
MORN repeat containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001304$repeat]
MORN repeat containing 3,UP_SEQ_FEATURE[850032493$chain:MORN repeat-containing protein 3, 850116382$repeat:MORN 1, 850116384$repeat:MORN 2, 850116385$repeat:MORN 3, 850116386$repeat:MORN 4, 850116387$repeat:MORN 5, 850116388$repeat:MORN 6, 850116389$repeat:MORN 7, 850118574$splice variant]
MYB binding protein (P160) 1a,INTERPRO[450006411$IPR007015:DNA polymerase V]
MYB binding protein (P160) 1a,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
MYB binding protein (P160) 1a,UP_SEQ_FEATURE[850032868$chain:Myb-binding protein 1A, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue, 850112572$region of interest:Interaction with MYB, 850114435$region of interest:Required for nuclear and nucleolar localization, 850117294$sequence conflict, 850117295$sequence variant, 850117606$short sequence motif:Nuclear export signal 1, 850117607$short sequence motif:Nuclear export signal 2, 850118574$splice variant]
MYST histone acetyltransferase (monocytic leukemia) 3,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450002410$IPR002717:MOZ/SAS-like protein, 450005266$IPR005818:Histone H1/H5, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014522$IPR016181:Acyl-CoA N-acyltransferase, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
MYST histone acetyltransferase (monocytic leukemia) 3,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000466$SM00526:H15]
MYST histone acetyltransferase (monocytic leukemia) 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000025$Acyltransferase, 790000311$chromatin regulator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
MYST histone acetyltransferase (monocytic leukemia) 3,UP_SEQ_FEATURE[850023869$chain:Histone acetyltransferase MYST3, 850102501$compositionally biased region:Gln/Pro-rich, 850102507$compositionally biased region:Glu-rich, 850102562$compositionally biased region:Met-rich, 850102566$compositionally biased region:Poly-Arg, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850102581$compositionally biased region:Poly-Ser, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850110822$region of interest:Acetylcoenzyme A binding, 850111190$region of interest:Catalytic, 850112799$region of interest:Interaction with RUNX1-1, 850112800$region of interest:Interaction with RUNX1-2, 850113357$region of interest:Mediates interaction with BRPF1, required for histone H3 acetyltransferase activity, 850114232$region of interest:Required for activation of RUNX1-1, 850114233$region of interest:Required for activation of RUNX1-2, 850114436$region of interest:Required for nuclear localization, 850117294$sequence conflict, 850117295$sequence variant, 850117908$site:Breakpoint for translocation to form MYST3-ASXL2, 850117910$site:Breakpoint for translocation to form MYST3-CREBBP, 850117912$site:Breakpoint for translocation to form MYST3-EP300 and MYST3-NCOA2, 850118575$strand, 850118624$turn, 850118743$zinc finger region:C2HC-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
N-acetylated alpha-linked acidic dipeptidase-like 1,INTERPRO[450002761$IPR003137:Protease-associated PA, 450006727$IPR007365:Transferrin receptor-like, dimerisation, 450006838$IPR007484:Peptidase M28]
N-acetylated alpha-linked acidic dipeptidase-like 1,PIR_SUPERFAMILY[630002664$PIRSF002548:transferrin receptor]
N-acetylated alpha-linked acidic dipeptidase-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000242$carboxypeptidase, 790000264$cell membrane, 790000356$complete proteome, 790000438$dipeptidase, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790000993$multifunctional enzyme, 790001212$polymorphism, 790001252$Protease, 790001409$Signal-anchor, 790001555$transmembrane, 790001648$zinc]
N-acetylated alpha-linked acidic dipeptidase-like 1,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850000096$active site:Nucleophile; for NAALADase activity, 850033172$chain:N-acetylated-alpha-linked acidic dipeptidase-like protein, 850105770$glycosylation site:N-linked (GlcNAc...), 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850113538$region of interest:NAALADase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
N-acylethanolamine acid amidase,INTERPRO[450002816$IPR003199:Choloylglycine hydrolase, 450015019$IPR016699:Acid ceramidase-like]
N-acylethanolamine acid amidase,PIR_SUPERFAMILY[630014326$PIRSF017632:acid ceramidase, 630014327$PIRSF017632:Acid_ceramidase-like]
N-acylethanolamine acid amidase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000897$lysosome, 790001212$polymorphism, 790001405$signal]
N-acylethanolamine acid amidase,UP_SEQ_FEATURE[850033249$chain:N-acylethanolamine-hydrolyzing acid amidase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
N-methylpurine-DNA glycosylase,INTERPRO[450002797$IPR003180:Methylpurine-DNA glycosylase (MPG)]
N-methylpurine-DNA glycosylase,KEGG_PATHWAY[470038822$hsa03410:Base excision repair]
N-methylpurine-DNA glycosylase,PIR_SUPERFAMILY[630029368$PIRSF037794:DNA-3-methyladenine glycosylase]
N-methylpurine-DNA glycosylase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000617$glycosidase, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
N-methylpurine-DNA glycosylase,UP_SEQ_FEATURE[850015879$chain:DNA-3-methyladenine glycosylase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,COG_ONTOLOGY[90000073$General function prediction only]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,INTERPRO[450006016$IPR006596:Nucleotide binding protein, PINc, 450013330$IPR014881:Nin one binding (NOB1) Zn-ribbon like, 450015437$IPR017117:D-site 20S pre-rRNA nuclease]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,PIR_SUPERFAMILY[630028638$PIRSF037125:D-site_20S_pre-rRNA_nuclease]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,SMART[760000582$SM00670:PINc]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc]
NIN1/RPN12 binding protein 1 homolog (S. cerevisiae); hypothetical LOC100132364,UP_SEQ_FEATURE[850058526$chain:RNA-binding protein NOB1, 850102572$compositionally biased region:Poly-Glu, 850104997$domain:PINc, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
NLR family, pyrin domain containing 3,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450003152$IPR003590:Leucine-rich repeat, ribonuclease inhibitor subtype, 450003539$IPR004020:Pyrin, 450006487$IPR007111:NACHT nucleoside triphosphatase, 450010009$IPR011029:DEATH-like]
NLR family, pyrin domain containing 3,KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
NLR family, pyrin domain containing 3,OMIM_DISEASE[520001046$CINCA syndrome, 520001074$Cold-induced autoinflammatory syndrome, familial, 520003373$Muckle-Wells syndrome]
NLR family, pyrin domain containing 3,PIR_SUPERFAMILY[630029074$PIRSF037494:NALP protein]
NLR family, pyrin domain containing 3,SMART[760000332$SM00368:LRR_RI]
NLR family, pyrin domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000078$amyloidosis, 790000109$Apoptosis, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000415$deafness, 790000446$disease mutation, 790000853$leucine-rich repeat, 790001063$nucleotide-binding, 790001301$receptor, 790001304$repeat]
NLR family, pyrin domain containing 3,UP_SEQ_FEATURE[850033387$chain:NACHT, LRR and PYD domains-containing protein 3, 850102572$compositionally biased region:Poly-Glu, 850103482$domain:DAPIN, 850104825$domain:NACHT, 850106263$nucleotide phosphate-binding region:ATP, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae),INTERPRO[450005001$IPR005549:Kinetochore protein Nuf2]
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000827$kinetochore, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae),UP_SEQ_FEATURE[850027538$chain:Kinetochore protein Nuf2, 850105852$helix, 850106258$modified residue, 850112921$region of interest:Interaction with the C-terminus of NDC80 and the SPBC24-SPBC25 subcomplex, 850112934$region of interest:Interaction with the N-terminus of NDC80, 850117295$sequence variant, 850118575$strand]
PCTAIRE protein kinase 3,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450009944$IPR010916:TonB box, conserved site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
PCTAIRE protein kinase 3,SMART[760000193$SM00220:S_TKc]
PCTAIRE protein kinase 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
PCTAIRE protein kinase 3,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010438$chain:Cell division protein kinase 18, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
PHD finger protein 17,COG_ONTOLOGY[90000073$General function prediction only]
PHD finger protein 17,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450017779$IPR019542:Enhancer of polycomb-like, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
PHD finger protein 17,SMART[760000221$SM00249:PHD]
PHD finger protein 17,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
PHD finger protein 17,UP_SEQ_FEATURE[850046517$chain:Protein Jade-1, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118878$zinc finger region:PHD-type 1, 850118881$zinc finger region:PHD-type 2; atypical]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),INTERPRO[450003194$IPR003648:Splicing factor motif, 450003613$IPR004098:Prp18, 450013355$IPR014906:Pre-mRNA processing factor 4 (PRP4) like]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),PIR_SUPERFAMILY[630022606$PIRSF029771:pre-mRNA-splicing factor 18]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),SMART[760000443$SM00500:SFM]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001433$Spliceosome]
PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae),UP_SEQ_FEATURE[850040385$chain:Pre-mRNA-splicing factor 18, 850105852$helix, 850106258$modified residue, 850118574$splice variant, 850118575$strand]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),COG_ONTOLOGY[90000102$RNA processing and modification]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),INTERPRO[450000475$IPR000555:Mov34/MPN/PAD-1, 450011271$IPR012591:Pre-mRNA-processing-splicing factor 8, 450011272$IPR012592:PROCN, 450011660$IPR012984:PRO, C-terminal, 450017817$IPR019580:Pre-mRNA-processing-splicing factor 8, U6-snRNA binding, 450017818$IPR019581:Pre-mRNA-processing-splicing factor 8, U5-snRNA binding, 450017819$IPR019582:RNA recognition motif, spliceosomal PrP8]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),OMIM_DISEASE[520004287$Retinitis pigmentosa-13]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),SMART[760000204$SM00232:JAB_MPN]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001316$retinitis pigmentosa, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001377$sensory transduction, 790001433$Spliceosome, 790001622$vision]
PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),UP_SEQ_FEATURE[850040382$chain:Pre-mRNA-processing-splicing factor 8, 850104794$domain:MPN, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850113181$region of interest:Involved in interaction with pre-mRNA 5' splice site, 850114338$region of interest:Required for interaction with EFTUD2 and SNRNP200, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,INTERPRO[450000135$IPR000159:Ras-association]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,SMART[760000284$SM00314:RA]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,UP_SEQ_FEATURE[850056680$chain:Ras association domain-containing protein 7, 850102586$compositionally biased region:Pro-rich, 850105145$domain:Ras-associating, 850117295$sequence variant, 850118574$splice variant]
Rh blood group, CcEe antigens,INTERPRO[450001687$IPR001905:Ammonium transporter, 450001976$IPR002229:Blood group Rhesus C/E and D polypeptide]
Rh blood group, CcEe antigens,OMIM_DISEASE[520000615$Blood group, Rhesus, 520004327$Rh-null disease, amorph type]
Rh blood group, CcEe antigens,PIR_SUPERFAMILY[630014625$PIRSF017968:erythrocyte membrane protein RhD]
Rh blood group, CcEe antigens,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000194$blood group antigen, 790000356$complete proteome, 790000445$direct protein sequencing, 790000512$erythrocyte, 790000919$membrane, 790001212$polymorphism, 790001469$surface antigen, 790001555$transmembrane, 790001556$transmembrane protein]
Rh blood group, CcEe antigens,UP_SEQ_FEATURE[850008177$chain:Blood group Rh(CE) polypeptide, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
S100 calcium binding protein A4,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A4,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000211$calcium, 790000212$calcium binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000480$EF hand, 790001304$repeat]
S100 calcium binding protein A4,UP_SEQ_FEATURE[850000620$calcium-binding region:1; low affinity, 850000624$calcium-binding region:2; high affinity, 850047562$chain:Protein S100-A4, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
SMAD family member 6,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes]
SMAD family member 6,INTERPRO[450000993$IPR001132:SMAD domain, Dwarfin-type, 450003179$IPR003619:MAD homology 1, Dwarfin-type, 450011686$IPR013019:MAD homology, MH1, 450012402$IPR013790:Dwarfin, 450016174$IPR017855:SMAD domain-like]
SMAD family member 6,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
SMAD family member 6,PIR_SUPERFAMILY[630028833$PIRSF037286:Smad protein, 630030640$PIRSF500412:inhibitory Smad protein, Smad 6/Smad 7 types]
SMAD family member 6,SMART[760000463$SM00523:DWA, 760000464$SM00524:DWB]
SMAD family member 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
SMAD family member 6,UP_SEQ_FEATURE[850032508$chain:Mothers against decapentaplegic homolog 6, 850102565$compositionally biased region:Poly-Ala, 850102566$compositionally biased region:Poly-Arg, 850102573$compositionally biased region:Poly-Gly, 850102576$compositionally biased region:Poly-Leu, 850102580$compositionally biased region:Poly-Pro, 850104765$domain:MH1, 850104766$domain:MH2, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
SMAD specific E3 ubiquitin protein ligase 1,BIOCARTA[30000090$h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth]
SMAD specific E3 ubiquitin protein ligase 1,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450000485$IPR000569:HECT, 450001055$IPR001202:WW/Rsp5/WWP, 450016334$IPR018029:C2 membrane targeting protein]
SMAD specific E3 ubiquitin protein ligase 1,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038841$hsa04144:Endocytosis, 470038850$hsa04350:TGF-beta signaling pathway]
SMAD specific E3 ubiquitin protein ligase 1,PIR_SUPERFAMILY[630001740$PIRSF001569:E3 ubiquitin-protein ligase, Nedd4/Rsp5p types, 630030673$PIRSF500454:smad ubiquitination regulatory factor]
SMAD specific E3 ubiquitin protein ligase 1,SMART[760000104$SM00119:HECTc, 760000211$SM00239:C2, 760000401$SM00456:WW]
SMAD specific E3 ubiquitin protein ligase 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000859$ligase, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
SMAD specific E3 ubiquitin protein ligase 1,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850016753$chain:E3 ubiquitin-protein ligase SMURF1, 850103199$domain:C2, 850104105$domain:HECT, 850105732$domain:WW 1, 850105733$domain:WW 2, 850106259$mutagenesis site, 850117295$sequence variant, 850118574$splice variant]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,BIOCARTA[30000142$h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes, 30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,INTERPRO[450000283$IPR000330:SNF2-related, 450001324$IPR001487:Bromodomain, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450005982$IPR006562:HSA, 450005996$IPR006576:BRK domain, 450012593$IPR013999:HAS subgroup, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012606$IPR014012:Helicase/SANT-associated, DNA binding, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding, 450013427$IPR014978:Glutamine-Leucine-Glutamine, QLQ, 450016644$IPR018359:Bromodomain, conserved site]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,PIR_SUPERFAMILY[630027745$PIRSF036309:SNF2-family ATP-dependent chromatin remodeling factor, 630031063$PIRSF500926:SWI/SNF related, matrix associated, actin dependent regulator of chromatin]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,SMART[760000267$SM00297:BROMO, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc, 760000510$SM00573:HSA, 760000526$SM00592:BRK]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000020$activator, 790000138$atp-binding, 790000206$bromodomain, 790000311$chromatin regulator, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4,UP_SEQ_FEATURE[850064930$chain:Transcription activator BRG1, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850103166$domain:Bromo, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850104152$domain:HSA, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850113649$region of interest:Necessary for interaction with SS18L1/CREST, 850117294$sequence conflict, 850117295$sequence variant, 850117399$short sequence motif:DEGH box, 850118516$site:Required for binding to 'Lys-15'- acetylated histone 3, 850118575$strand, 850118624$turn]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,BIOCARTA[30000314$h_WNVpathway:West Nile Virus]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,COG_ONTOLOGY[90000073$General function prediction only]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,SMART[760000328$SM00360:RRM]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000109$Apoptosis, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,UP_SEQ_FEATURE[850035207$chain:Nucleolysin TIAR, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
TNF receptor-associated factor 3 interacting protein 1,INTERPRO[450017071$IPR018799:Microtubule/TRAF3 and DISC1 binding protein]
TNF receptor-associated factor 3 interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism]
TNF receptor-associated factor 3 interacting protein 1,UP_SEQ_FEATURE[850064875$chain:TRAF3-interacting protein 1, 850102404$compositionally biased region:Arg-rich, 850105852$helix, 850106258$modified residue, 850110809$region of interest:Abolishes microtubules-binding when missing, 850111443$region of interest:DISC1-interaction domain, 850117295$sequence variant, 850118574$splice variant, 850118624$turn]
TYRO protein tyrosine kinase binding protein,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity]
TYRO protein tyrosine kinase binding protein,OMIM_DISEASE[520003553$Nasu-Hakola disease]
TYRO protein tyrosine kinase binding protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
TYRO protein tyrosine kinase binding protein,UP_SEQ_FEATURE[850067522$chain:TYRO protein tyrosine kinase-binding protein, 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Tax1 (human T-cell leukemia virus type I) binding protein 3,BIOCARTA[30000296$h_tidPathway:Chaperones modulate interferon Signaling Pathway]
Tax1 (human T-cell leukemia virus type I) binding protein 3,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450015590$IPR017268:Tax1-binding protein 3]
Tax1 (human T-cell leukemia virus type I) binding protein 3,PIR_SUPERFAMILY[630029285$PIRSF037712:Tax1-binding protein 3, 630029286$PIRSF037712:Tax1-binding_p3]
Tax1 (human T-cell leukemia virus type I) binding protein 3,SMART[760000200$SM00228:PDZ]
Tax1 (human T-cell leukemia virus type I) binding protein 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001642$wnt signaling pathway]
Tax1 (human T-cell leukemia virus type I) binding protein 3,UP_SEQ_FEATURE[850063636$chain:Tax1-binding protein 3, 850104918$domain:PDZ, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
Y box binding protein 2,INTERPRO[450001824$IPR002059:Cold-shock protein, DNA-binding, 450010069$IPR011129:Cold shock protein, 450011038$IPR012340:Nucleic acid-binding, OB-fold, 450018074$IPR019844:Cold-shock conserved site]
Y box binding protein 2,SMART[760000325$SM00357:CSP]
Y box binding protein 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
Y box binding protein 2,UP_SEQ_FEATURE[850101105$chain:Y-box-binding protein 2, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850103420$domain:CSD, 850106258$modified residue, 850114280$region of interest:Required for cytoplasmic retention, 850114432$region of interest:Required for mRNA-binding, 850117295$sequence variant]
Yip1 domain family, member 3,INTERPRO[450006375$IPR006977:Yip1 domain]
Yip1 domain family, member 3,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000434$differentiation, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
Yip1 domain family, member 3,UP_SEQ_FEATURE[850048517$chain:Protein YIPF3, 850117294$sequence conflict, 850117295$sequence variant, 850118450$site:Not glycosylated, 850118623$transmembrane region]
abhydrolase domain containing 12,INTERPRO[450000062$IPR000073:Alpha/beta hydrolase fold-1]
abhydrolase domain containing 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
abhydrolase domain containing 12,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850032401$chain:Monoacylglycerol lipase ABHD12, 850102565$compositionally biased region:Poly-Ala, 850102581$compositionally biased region:Poly-Ser, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
abl interactor 2,BIOCARTA[30000006$h_actinYPathway:Y branching of actin filaments]
abl interactor 2,INTERPRO[450000090$IPR000108:Neutrophil cytosol factor 2, 450000626$IPR000727:Target SNARE coiled-coil region, 450001294$IPR001452:Src homology-3 domain, 450011527$IPR012849:Abl-interactor, homeo-domain homologous region]
abl interactor 2,KEGG_PATHWAY[470038881$hsa04810:Regulation of actin cytoskeleton]
abl interactor 2,OMIM_DISEASE[520002012$Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study]
abl interactor 2,SMART[760000295$SM00326:SH3, 760000348$SM00397:t_SNARE]
abl interactor 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001398$sh3 domain]
abl interactor 2,UP_SEQ_FEATURE[850003176$chain:Abl interactor 2, 850102586$compositionally biased region:Pro-rich, 850105350$domain:SH3, 850105459$domain:t-SNARE coiled-coil homology, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
adaptor-related protein complex 3, delta 1 subunit,COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
adaptor-related protein complex 3, delta 1 subunit,INTERPRO[450002270$IPR002553:Clathrin/coatomer adaptor, adaptin-like, N-terminal, 450009533$IPR010474:Bovine leukaemia virus receptor, 450010814$IPR011989:Armadillo-like helical, 450015425$IPR017105:Adaptor protein complex AP-3, delta subunit]
adaptor-related protein complex 3, delta 1 subunit,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
adaptor-related protein complex 3, delta 1 subunit,PIR_SUPERFAMILY[630028593$PIRSF037092:adaptor protein complex AP-3, delta subunit, 630028594$PIRSF037092:AP3_complex_delta]
adaptor-related protein complex 3, delta 1 subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
adaptor-related protein complex 3, delta 1 subunit,UP_SEQ_FEATURE[850005731$chain:AP-3 complex subunit delta-1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
adducin 1 (alpha),BIOCARTA[30000223$h_PDZsPathway:Synaptic Proteins at the Synaptic Junction]
adducin 1 (alpha),INTERPRO[450001148$IPR001303:Class II aldolase/adducin, N-terminal]
adducin 1 (alpha),OMIM_DISEASE[520002478$Hypertension, essential, salt-sensitive]
adducin 1 (alpha),SP_PIR_KEYWORDS[790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
adducin 1 (alpha),UP_SEQ_FEATURE[850004690$chain:Alpha-adducin, 850106258$modified residue, 850106259$mutagenesis site, 850112141$region of interest:Interaction with calmodulin, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
amyotrophic lateral sclerosis 2 (juvenile),COG_ONTOLOGY[90000026$Cell division and chromosome partitioning / Cytoskeleton, 90000070$Function unknown]
amyotrophic lateral sclerosis 2 (juvenile),INTERPRO[450000189$IPR000219:Dbl homology (DH) domain, 450000351$IPR000408:Regulator of chromosome condensation, RCC1, 450001173$IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site, 450001635$IPR001849:Pleckstrin homology, 450002747$IPR003123:Vacuolar sorting protein 9, 450002977$IPR003409:MORN motif, 450008218$IPR009091:Regulator of chromosome condensation/beta-lactamase-inhibitor protein II]
amyotrophic lateral sclerosis 2 (juvenile),KEGG_PATHWAY[470038893$hsa05014:Amyotrophic lateral sclerosis (ALS)]
amyotrophic lateral sclerosis 2 (juvenile),OMIM_DISEASE[520000290$Amyotrophic lateral sclerosis, juvenile, 520004098$Primary lateral sclerosis, juvenile, 520004534$Spastic paralysis, infantile onset ascending]
amyotrophic lateral sclerosis 2 (juvenile),SMART[760000205$SM00233:PH, 760000294$SM00325:RhoGEF, 760000606$SM00698:MORN]
amyotrophic lateral sclerosis 2 (juvenile),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000080$amyotrophic lateral sclerosis, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790001015$neurodegeneration, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
amyotrophic lateral sclerosis 2 (juvenile),UP_SEQ_FEATURE[850004935$chain:Alsin, 850103518$domain:DH, 850104979$domain:PH, 850105626$domain:VPS9, 850106258$modified residue, 850116382$repeat:MORN 1, 850116384$repeat:MORN 2, 850116385$repeat:MORN 3, 850116386$repeat:MORN 4, 850116387$repeat:MORN 5, 850116388$repeat:MORN 6, 850116389$repeat:MORN 7, 850116390$repeat:MORN 8, 850116898$repeat:RCC1 1, 850116909$repeat:RCC1 2, 850116910$repeat:RCC1 3, 850116911$repeat:RCC1 4, 850116912$repeat:RCC1 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ankyrin repeat and SOCS box-containing 6,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001870$IPR002110:Ankyrin]
ankyrin repeat and SOCS box-containing 6,SMART[760000220$SM00248:ANK, 760000225$SM00253:SOCS]
ankyrin repeat and SOCS box-containing 6,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790000407$cytoplasm, 790001304$repeat, 790001593$ubl conjugation pathway]
ankyrin repeat and SOCS box-containing 6,UP_SEQ_FEATURE[850005353$chain:Ankyrin repeat and SOCS box protein 6, 850105375$domain:SOCS box, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6]
ankyrin repeat domain 2 (stretch responsive muscle),INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 2 (stretch responsive muscle),SMART[760000220$SM00248:ANK]
ankyrin repeat domain 2 (stretch responsive muscle),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000244$cardiac muscle, 790000356$complete proteome, 790000646$heart, 790001212$polymorphism, 790001304$repeat, 790001415$skeletal muscle]
ankyrin repeat domain 2 (stretch responsive muscle),UP_SEQ_FEATURE[850005372$chain:Ankyrin repeat domain-containing protein 2, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ankyrin repeat domain 40,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 40,PIR_SUPERFAMILY[630028847$PIRSF037301:uncharacterized protein with ankyrin repeat domain, ANKRD40 type]
ankyrin repeat domain 40,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 40,SP_PIR_KEYWORDS[790000012$acetylation, 790000086$ank repeat, 790000356$complete proteome, 790000445$direct protein sequencing, 790001304$repeat]
ankyrin repeat domain 40,UP_SEQ_FEATURE[850005399$chain:Ankyrin repeat domain-containing protein 40, 850102568$compositionally biased region:Poly-Asp, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850117294$sequence conflict]
apoptosis-associated tyrosine kinase,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450007559$IPR008266:Tyrosine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site]
apoptosis-associated tyrosine kinase,SMART[760000192$SM00219:TyrKc]
apoptosis-associated tyrosine kinase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001555$transmembrane]
apoptosis-associated tyrosine kinase,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059842$chain:Serine/threonine-protein kinase LMTK1, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850105086$domain:Protein kinase, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
axin 1,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000227$h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2, 30000240$h_ps1Pathway:Presenilin action in Notch and Wnt signaling, 30000313$h_wntPathway:WNT Signaling Pathway]
axin 1,INTERPRO[450000294$IPR000342:Regulator of G protein signalling, 450001015$IPR001158:DIX, 450013385$IPR014936:Axin beta-catenin binding]
axin 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038903$hsa05213:Endometrial cancer, 470038907$hsa05217:Basal cell carcinoma]
axin 1,OMIM_DISEASE[520000875$Caudal duplication anomaly, 520002293$Hepatocellular carcinoma, somatic]
axin 1,PIR_SUPERFAMILY[630029842$PIRSF038234:axis inhibition protein (axin)]
axin 1,SMART[760000014$SM00021:DAX, 760000285$SM00315:RGS]
axin 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000446$disease mutation, 790001162$phosphoprotein, 790001580$tumor suppressor, 790001642$wnt signaling pathway]
axin 1,UP_SEQ_FEATURE[850007014$chain:Axin-1, 850103527$domain:DIX, 850105178$domain:RGS, 850105852$helix, 850106258$modified residue, 850112126$region of interest:Interaction with beta-catenin, 850112379$region of interest:Interaction with GSK3B, 850112396$region of interest:Interaction with HIPK2, 850112787$region of interest:Interaction with RNF111, 850112962$region of interest:Interaction with TP53, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118624$turn]
calcineurin-like phosphoesterase domain containing 1,INTERPRO[450004322$IPR004843:Metallophosphoesterase]
calcineurin-like phosphoesterase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790001212$polymorphism]
calcineurin-like phosphoesterase domain containing 1,UP_SEQ_FEATURE[850008911$chain:Calcineurin-like phosphoesterase domain- containing protein 1, 850105987$metal ion-binding site:Divalent metal cation 1, 850105990$metal ion-binding site:Divalent metal cation 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,KEGG_PATHWAY[470038886$hsa04920:Adipocytokine signaling pathway]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,SMART[760000193$SM00220:S_TKc]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
calcium/calmodulin-dependent protein kinase kinase 1, alpha,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009078$chain:Calcium/calmodulin-dependent protein kinase kinase 1, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110972$region of interest:Autoinhibitory domain, 850111164$region of interest:Calmodulin-binding, 850114558$region of interest:RP domain, 850117295$sequence variant, 850118574$splice variant]
cardiotrophin-like cytokine factor 1,INTERPRO[450009726$IPR010681:Plethodontid receptivity factor PRF]
cardiotrophin-like cytokine factor 1,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
cardiotrophin-like cytokine factor 1,OMIM_DISEASE[520001076$Cold-induced sweating syndrome 1]
cardiotrophin-like cytokine factor 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000402$cytokine, 790000446$disease mutation, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
cardiotrophin-like cytokine factor 1,UP_SEQ_FEATURE[850009721$chain:Cardiotrophin-like cytokine factor 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
casein kinase 1, alpha 1,BIOCARTA[30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart), 30000214$h_p35alzheimersPathway:Deregulation of CDK5 in Alzheimers Disease, 30000216$h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system, 30000313$h_wntPathway:WNT Signaling Pathway]
casein kinase 1, alpha 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
casein kinase 1, alpha 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038849$hsa04340:Hedgehog signaling pathway]
casein kinase 1, alpha 1,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein, 630031202$PIRSF501113:casein kinase 1]
casein kinase 1, alpha 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000825$kinase, 790000827$kinetochore, 790000973$mitosis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001642$wnt signaling pathway]
casein kinase 1, alpha 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009774$chain:Casein kinase I isoform alpha, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
casein kinase 1, delta,BIOCARTA[30000065$h_ck1Pathway:Regulation of ck1/cdk5 by type 1 glutamate receptors]
casein kinase 1, delta,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
casein kinase 1, delta,KEGG_PATHWAY[470038849$hsa04340:Hedgehog signaling pathway, 470038858$hsa04540:Gap junction, 470038875$hsa04710:Circadian rhythm]
casein kinase 1, delta,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein, 630031202$PIRSF501113:casein kinase 1]
casein kinase 1, delta,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001642$wnt signaling pathway]
casein kinase 1, delta,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009777$chain:Casein kinase I isoform delta, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110970$region of interest:Autoinhibitory, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
caspase recruitment domain family, member 11,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
caspase recruitment domain family, member 11,INTERPRO[450001158$IPR001315:Caspase Recruitment, 450001316$IPR001478:PDZ/DHR/GLGF, 450007477$IPR008144:Guanylate kinase]
caspase recruitment domain family, member 11,KEGG_PATHWAY[470038869$hsa04660:T cell receptor signaling pathway, 470038870$hsa04662:B cell receptor signaling pathway]
caspase recruitment domain family, member 11,PIR_SUPERFAMILY[630029128$PIRSF037539:PIRSF037539]
caspase recruitment domain family, member 11,SMART[760000101$SM00114:CARD, 760000200$SM00228:PDZ]
caspase recruitment domain family, member 11,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
caspase recruitment domain family, member 11,UP_SEQ_FEATURE[850009805$chain:Caspase recruitment domain-containing protein 11, 850103287$domain:CARD, 850104093$domain:Guanylate kinase-like, 850104918$domain:PDZ, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
centrobin, centrosomal BRCA2 interacting protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism]
centrobin, centrosomal BRCA2 interacting protein,UP_SEQ_FEATURE[850010652$chain:Centrobin, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850114271$region of interest:Required for centrosome localization, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
centrosome and spindle pole associated protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000960$microtubule, 790001162$phosphoprotein, 790001212$polymorphism]
centrosome and spindle pole associated protein 1,UP_SEQ_FEATURE[850010708$chain:Centrosome and spindle pole-associated protein 1, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chemokine (C-X-C motif) receptor 5,BBID[10000043$16.Chemokines-rec-T-cells]
chemokine (C-X-C motif) receptor 5,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000922$IPR001053:C-X-C chemokine receptor, type 5, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
chemokine (C-X-C motif) receptor 5,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
chemokine (C-X-C motif) receptor 5,PIR_SUPERFAMILY[630030051$PIRSF038545:chemokine receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
chemokine (C-X-C motif) receptor 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000153$b-cell activation, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
chemokine (C-X-C motif) receptor 5,UP_SEQ_FEATURE[850008769$chain:C-X-C chemokine receptor type 5, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromatin modifying protein 5,INTERPRO[450004493$IPR005024:Snf7]
chromatin modifying protein 5,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
chromatin modifying protein 5,PIR_SUPERFAMILY[630022941$PIRSF030206:ESCRT-3 complex, Chmp4/Chmp5/Chmp6 subunits, 630031004$PIRSF500852:ESCRT-3 complex, Chmp5 subunit]
chromatin modifying protein 5,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000501$endosome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
chromatin modifying protein 5,UP_SEQ_FEATURE[850010891$chain:Charged multivesicular body protein 5, 850106258$modified residue, 850113035$region of interest:Interaction with VTA1, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 1 open reading frame 66,INTERPRO[450001540$IPR001737:Ribosomal RNA adenine methylase transferase]
chromosome 1 open reading frame 66,SMART[760000565$SM00650:rADc]
chromosome 1 open reading frame 66,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 1 open reading frame 66,UP_SEQ_FEATURE[850096686$chain:UPF0431 protein C1orf66, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
chromosome 16 open reading frame 65,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF]
chromosome 16 open reading frame 65,SMART[760000200$SM00228:PDZ]
chromosome 16 open reading frame 65,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 16 open reading frame 65,UP_SEQ_FEATURE[850036990$chain:PDZ domain-containing protein C16orf65, 850104918$domain:PDZ, 850118574$splice variant]
chromosome 16 open reading frame 71,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 16 open reading frame 71,UP_SEQ_FEATURE[850073314$chain:Uncharacterized protein C16orf71, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 17 open reading frame 91,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 17 open reading frame 91,UP_SEQ_FEATURE[850055239$chain:Putative uncharacterized protein C17orf91, 850117294$sequence conflict]
chromosome 19 open reading frame 22,INTERPRO[450001219$IPR001374:Single-stranded nucleic acid binding R3H]
chromosome 19 open reading frame 22,SMART[760000345$SM00393:R3H]
chromosome 19 open reading frame 22,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus]
chromosome 19 open reading frame 22,UP_SEQ_FEATURE[850056504$chain:R3H domain-containing protein C19orf22, 850102404$compositionally biased region:Arg-rich, 850105134$domain:R3H]
chromosome 19 open reading frame 40,SP_PIR_KEYWORDS[790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism]
chromosome 19 open reading frame 40,UP_SEQ_FEATURE[850018972$chain:Fanconi anemia-associated protein of 24 kDa, 850114564$region of interest:RuvA domain 2-like, 850117295$sequence variant]
chromosome 19 open reading frame 47,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 19 open reading frame 47,UP_SEQ_FEATURE[850073519$chain:Uncharacterized protein C19orf47, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850118574$splice variant]
chromosome 2 open reading frame 16,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
chromosome 2 open reading frame 16,UP_SEQ_FEATURE[850073931$chain:Uncharacterized protein C2orf16, 850102404$compositionally biased region:Arg-rich, 850106258$modified residue, 850110164$region of interest:27 X 8 AA approximative tandem repeat of P-S-E-R-S-H-H-S, 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115380$repeat:24, 850115392$repeat:25, 850115404$repeat:26, 850115408$repeat:27, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 3 open reading frame 48,INTERPRO[450001711$IPR001932:Protein phosphatase 2C-related, 450014091$IPR015655:Protein phosphatase 2C]
chromosome 3 open reading frame 48,SMART[760000300$SM00331:PP2C_SIG, 760000301$SM00332:PP2Cc]
chromosome 3 open reading frame 52,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 3 open reading frame 52,UP_SEQ_FEATURE[850064805$chain:TPA-induced transmembrane protein, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 5 open reading frame 53,SP_PIR_KEYWORDS[790000356$complete proteome, 790001363$Secreted, 790001405$signal]
chromosome 5 open reading frame 53,UP_SEQ_FEATURE[850025531$chain:IgA-inducing protein homolog, 850117814$signal peptide]
chromosome 6 open reading frame 108,INTERPRO[450007065$IPR007710:Nucleoside 2-deoxyribosyltransferase]
chromosome 6 open reading frame 108,PIR_SUPERFAMILY[630028710$PIRSF037191:nucleoside 2-deoxyribosyltransferase, Rcl type]
chromosome 6 open reading frame 108,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000617$glycosidase, 790000743$hydrolase, 790001062$nucleotide metabolism, 790001065$nucleus, 790001162$phosphoprotein]
chromosome 6 open reading frame 108,UP_SEQ_FEATURE[850000555$binding site:Substrate, 850014880$chain:Deoxyribonucleoside 5'-monophosphate N- glycosidase, 850106258$modified residue]
coagulation factor II (thrombin) receptor-like 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450002027$IPR002281:Protease-activated receptor 2, 450003437$IPR003912:Protease-activated receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
coagulation factor II (thrombin) receptor-like 1,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
coagulation factor II (thrombin) receptor-like 1,PIR_SUPERFAMILY[630029569$PIRSF037996:proteinase-activated receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
coagulation factor II (thrombin) receptor-like 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
coagulation factor II (thrombin) receptor-like 1,UP_SEQ_FEATURE[850048652$chain:Proteinase-activated receptor 2, 850102581$compositionally biased region:Poly-Ser, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850109698$propeptide:Removed for receptor activation, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118130$site:Cleavage; by trypsin, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
coagulation factor VIII-associated (intronic transcript) 2; coagulation factor VIII-associated (intronic transcript) 3; coagulation factor VIII-associated (intronic transcript) 1,PIR_SUPERFAMILY[630016142$PIRSF019545:factor VIII intron 22 protein]
coagulation factor VIII-associated (intronic transcript) 2; coagulation factor VIII-associated (intronic transcript) 3; coagulation factor VIII-associated (intronic transcript) 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome]
coagulation factor VIII-associated (intronic transcript) 2; coagulation factor VIII-associated (intronic transcript) 3; coagulation factor VIII-associated (intronic transcript) 1,UP_SEQ_FEATURE[850018906$chain:Factor VIII intron 22 protein, 850106258$modified residue, 850117294$sequence conflict]
coiled-coil domain containing 64B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
coiled-coil domain containing 64B,UP_SEQ_FEATURE[850012036$chain:Coiled-coil domain-containing protein 64B, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
cytochrome P450, family 7, subfamily A, polypeptide 1,BIOCARTA[30000118$h_fxrPathway:FXR and LXR Regulation of Cholesterol Metabolism, 30000211$h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity]
cytochrome P450, family 7, subfamily A, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 7, subfamily A, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002136$IPR002403:Cytochrome P450, E-class, group IV, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 7, subfamily A, polypeptide 1,KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis, 470038739$hsa00140:Steroid hormone biosynthesis, 470038821$hsa03320:PPAR signaling pathway]
cytochrome P450, family 7, subfamily A, polypeptide 1,PIR_SUPERFAMILY[630000060$PIRSF000047:cytochrome P450, CYP7A1 type, 630030816$PIRSF500625:cytochrome P450 7A1]
cytochrome P450, family 7, subfamily A, polypeptide 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000305$cholesterol metabolism, 790000314$chromoprotein, 790000356$complete proteome, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000873$lipid metabolism, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000959$microsome, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001442$steroid metabolism, 790001556$transmembrane protein]
cytochrome P450, family 7, subfamily A, polypeptide 1,UP_SEQ_FEATURE[850011193$chain:Cholesterol 7-alpha-monooxygenase, 850105852$helix, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
cytohesin 3,BIOCARTA[30000022$h_arapPathway:ADP-Ribosylation Factor]
cytohesin 3,INTERPRO[450000787$IPR000904:SEC7-like, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
cytohesin 3,PIR_SUPERFAMILY[630005444$PIRSF005519:cytohesin]
cytohesin 3,SMART[760000194$SM00222:Sec7, 760000205$SM00233:PH]
cytohesin 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor]
cytohesin 3,UP_SEQ_FEATURE[850013987$chain:Cytohesin-3, 850104979$domain:PH, 850105336$domain:SEC7, 850118574$splice variant]
dachsous 2 (Drosophila),INTERPRO[450001884$IPR002126:Cadherin]
dachsous 2 (Drosophila),SMART[760000099$SM00112:CA]
dachsous 2 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
dachsous 2 (Drosophila),UP_SEQ_FEATURE[850048758$chain:Protocadherin-23, 850103211$domain:Cadherin 1, 850103212$domain:Cadherin 10, 850103213$domain:Cadherin 11, 850103214$domain:Cadherin 12, 850103215$domain:Cadherin 13, 850103216$domain:Cadherin 14, 850103217$domain:Cadherin 15, 850103218$domain:Cadherin 16, 850103219$domain:Cadherin 17, 850103220$domain:Cadherin 18, 850103221$domain:Cadherin 19, 850103222$domain:Cadherin 2, 850103223$domain:Cadherin 20, 850103224$domain:Cadherin 21, 850103225$domain:Cadherin 22, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850103242$domain:Cadherin 7, 850103243$domain:Cadherin 8, 850103244$domain:Cadherin 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
dedicator of cytokinesis 8,INTERPRO[450009747$IPR010703:Dedicator of cytokinesis]
dedicator of cytokinesis 8,OMIM_DISEASE[520003160$Mental retardation, autosomal dominant 2]
dedicator of cytokinesis 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790001162$phosphoprotein, 790001212$polymorphism]
dedicator of cytokinesis 8,UP_SEQ_FEATURE[850014452$chain:Dedicator of cytokinesis protein 8, 850103522$domain:DHR-1, 850103523$domain:DHR-2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
deoxyribonuclease I-like 1,INTERPRO[450004603$IPR005135:Endonuclease/exonuclease/phosphatase, 450007506$IPR008185:Deoxyribonuclease I, eukaryotic, 450014526$IPR016202:Deoxyribonuclease I-like, 450016360$IPR018057:Deoxyribonuclease I, active site]
deoxyribonuclease I-like 1,PIR_SUPERFAMILY[630001140$PIRSF000988:deoxyribonuclease I, 630001141$PIRSF000988:DNase_I_euk]
deoxyribonuclease I-like 1,SMART[760000421$SM00476:DNaseIc]
deoxyribonuclease I-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000498$Endonuclease, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism, 790001405$signal]
deoxyribonuclease I-like 1,UP_SEQ_FEATURE[850014875$chain:Deoxyribonuclease-1-like 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
dephospho-CoA kinase domain containing,COG_ONTOLOGY[90000046$Coenzyme metabolism]
dephospho-CoA kinase domain containing,INTERPRO[450001751$IPR001977:Dephospho-CoA kinase]
dephospho-CoA kinase domain containing,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790001063$nucleotide-binding, 790001212$polymorphism]
dephospho-CoA kinase domain containing,UP_SEQ_FEATURE[850014897$chain:Dephospho-CoA kinase domain-containing protein, 850103544$domain:DPCK, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dynactin 4 (p62),INTERPRO[450007864$IPR008603:Dynactin p62]
dynactin 4 (p62),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynactin 4 (p62),SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
dynactin 4 (p62),UP_SEQ_FEATURE[850016481$chain:Dynactin subunit 4, 850106258$modified residue, 850117295$sequence variant]
dynein, axonemal, heavy chain 1,COG_ONTOLOGY[90000053$Cytoskeleton]
dynein, axonemal, heavy chain 1,INTERPRO[450003782$IPR004273:Dynein heavy chain, 450010532$IPR011704:ATPase associated with various cellular activities, AAA-5, 450012226$IPR013602:Dynein heavy chain, N-terminal region 2]
dynein, axonemal, heavy chain 1,KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynein, axonemal, heavy chain 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000267$cell projection, 790000321$cilium, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000475$dynein, 790000853$leucine-rich repeat, 790000960$microtubule, 790000986$motor protein, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
dynein, axonemal, heavy chain 1,UP_SEQ_FEATURE[850016515$chain:Dynein heavy chain 1, axonemal, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110798$region of interest:AAA 1, 850110799$region of interest:AAA 2, 850110800$region of interest:AAA 3, 850110801$region of interest:AAA 4, 850110802$region of interest:AAA 5, 850110803$region of interest:AAA 6, 850114695$region of interest:Stalk, 850114697$region of interest:Stem, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116316$repeat:LRR 17, 850116317$repeat:LRR 18, 850116318$repeat:LRR 19, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117339$short sequence motif:CFDEFNR motif, 850117472$short sequence motif:GPAGTGKT motif, 850118574$splice variant]
enoyl Coenzyme A hydratase domain containing 1,COG_ONTOLOGY[90000084$Lipid metabolism]
enoyl Coenzyme A hydratase domain containing 1,INTERPRO[450001553$IPR001753:Crotonase, core, 450016658$IPR018376:Enoyl-CoA hydratase/isomerase, conserved site]
enoyl Coenzyme A hydratase domain containing 1,OMIM_DISEASE[520002020$Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33]
enoyl Coenzyme A hydratase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000810$Isomerase]
enoyl Coenzyme A hydratase domain containing 1,UP_SEQ_FEATURE[850017503$chain:Enoyl-CoA hydratase domain-containing protein 1, 850118574$splice variant]
ephrin-A2,INTERPRO[450001592$IPR001799:Ephrin, 450008178$IPR008972:Cupredoxin, 450018000$IPR019765:Ephrin, conserved site]
ephrin-A2,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
ephrin-A2,PIR_SUPERFAMILY[630005696$PIRSF005772:Ephrin-A]
ephrin-A2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000881$lipoprotein, 790000919$membrane, 790001405$signal]
ephrin-A2,UP_SEQ_FEATURE[850017629$chain:Ephrin-A2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105856$lipid moiety-binding region:GPI-anchor amidated asparagine, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117814$signal peptide]
epoxide hydrolase 4,INTERPRO[450000062$IPR000073:Alpha/beta hydrolase fold-1, 450000546$IPR000639:Epoxide hydrolase-like]
epoxide hydrolase 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
epoxide hydrolase 4,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000114$active site:Proton acceptor, 850000131$active site:Proton donor, 850017716$chain:Epoxide hydrolase 4, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa,BIOCARTA[30000094$h_eif2Pathway:Regulation of eIF2, 30000146$h_igf1mtorpathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway]
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa,INTERPRO[450000689$IPR000795:Protein synthesis factor, GTP-binding, 450003671$IPR004161:Translation elongation factor EFTu/EF1A, domain 2, 450013701$IPR015256:Initiation factor eIF2 gamma, C-terminal]
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa,PIR_SUPERFAMILY[630003109$PIRSF003021:translation initiation factor eIF-2 gamma chain]
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000637$GTP binding, 790000639$gtp-binding, 790000776$Initiation factor, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis]
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa,UP_SEQ_FEATURE[850018083$chain:Eukaryotic translation initiation factor 2 subunit 3, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant]
eukaryotic translation initiation factor 4H,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
eukaryotic translation initiation factor 4H,SMART[760000328$SM00360:RRM]
eukaryotic translation initiation factor 4H,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000776$Initiation factor, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001339$rna-binding, 790001640$williams-beuren syndrome]
eukaryotic translation initiation factor 4H,UP_SEQ_FEATURE[850018149$chain:Eukaryotic translation initiation factor 4H, 850105211$domain:RRM, 850106258$modified residue, 850111871$region of interest:HHV-1 Vhs binding site, 850118574$splice variant]
exosome component 7,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
exosome component 7,INTERPRO[450001098$IPR001247:Exoribonuclease, phosphorolytic domain 1, 450014270$IPR015847:Exoribonuclease, phosphorolytic domain 2]
exosome component 7,KEGG_PATHWAY[470038814$hsa03018:RNA degradation]
exosome component 7,PIR_SUPERFAMILY[630006618$PIRSF006657:exosome complex 3'-5' exonuclease]
exosome component 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000523$exonuclease, 790000526$exosome, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism, 790001339$rna-binding, 790001345$rrna processing]
exosome component 7,UP_SEQ_FEATURE[850018277$chain:Exosome complex exonuclease RRP42, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
family with sequence similarity 108, member A4; family with sequence similarity 108, member A5; family with sequence similarity 108, member A1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001363$Secreted, 790001405$signal]
family with sequence similarity 108, member A4; family with sequence similarity 108, member A5; family with sequence similarity 108, member A1,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850003167$chain:Abhydrolase domain-containing protein FAM108A1, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
family with sequence similarity 132, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
family with sequence similarity 132, member A,UP_SEQ_FEATURE[850045865$chain:Protein FAM132A, 850117295$sequence variant, 850117814$signal peptide]
family with sequence similarity 73, member B,INTERPRO[450017630$IPR019392:Protein of unknown function DUF2217]
family with sequence similarity 73, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 73, member B,UP_SEQ_FEATURE[850046045$chain:Protein FAM73B, 850102566$compositionally biased region:Poly-Arg, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 86, member B2; family with sequence similarity 86, member A; family with sequence similarity 86, member B1,INTERPRO[450017648$IPR019410:Methyltransferase-16, putative]
family with sequence similarity 86, member B2; family with sequence similarity 86, member A; family with sequence similarity 86, member B1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 86, member B2; family with sequence similarity 86, member A; family with sequence similarity 86, member B1,UP_SEQ_FEATURE[850046075$chain:Protein FAM86A, 850046076$chain:Protein FAM86B1, 850046077$chain:Protein FAM86B2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
forkhead box E1 (thyroid transcription factor 2),INTERPRO[450001565$IPR001766:Transcription factor, fork head, 450010816$IPR011991:Winged helix repressor DNA-binding, 450016421$IPR018122:Transcription factor, fork head, conserved site]
forkhead box E1 (thyroid transcription factor 2),OMIM_DISEASE[520000504$Bamforth-Lazarus syndrome]
forkhead box E1 (thyroid transcription factor 2),SMART[760000307$SM00339:FH]
forkhead box E1 (thyroid transcription factor 2),SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
forkhead box E1 (thyroid transcription factor 2),UP_SEQ_FEATURE[850019855$chain:Forkhead box protein E1, 850102378$compositionally biased region:Ala-rich, 850102565$compositionally biased region:Poly-Ala, 850102586$compositionally biased region:Pro-rich, 850102914$DNA-binding region:Fork-head, 850117295$sequence variant]
glucosamine-6-phosphate deaminase 1,INTERPRO[450004040$IPR004547:Glucosamine-6-phosphate isomerase, 450005580$IPR006148:Glucosamine/galactosamine-6-phosphate isomerase, 450016605$IPR018321:Glucosamine-6-phosphate isomerase, conserved site, 450016606$IPR018322:Glucosamine-6-phosphate isomerase, subgroup]
glucosamine-6-phosphate deaminase 1,KEGG_PATHWAY[470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
glucosamine-6-phosphate deaminase 1,PIR_SUPERFAMILY[630001648$PIRSF001483:glucosamine-6-phosphate isomerase]
glucosamine-6-phosphate deaminase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase]
glucosamine-6-phosphate deaminase 1,UP_SEQ_FEATURE[850000078$active site:For ring-opening step, 850000117$active site:Proton acceptor; for enolization step, 850000122$active site:Proton acceptor; for ring-opening step, 850021403$chain:Glucosamine-6-phosphate isomerase 1, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
glucose-6-phosphatase, catalytic subunit,INTERPRO[450000279$IPR000326:Phosphatidic acid phosphatase type 2/haloperoxidase, 450014599$IPR016275:Glucose-6-phosphatase]
glucose-6-phosphatase, catalytic subunit,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038730$hsa00052:Galactose metabolism, 470038765$hsa00500:Starch and sucrose metabolism, 470038882$hsa04910:Insulin signaling pathway, 470038886$hsa04920:Adipocytokine signaling pathway]
glucose-6-phosphatase, catalytic subunit,OMIM_DISEASE[520002143$Glycogen storage disease I]
glucose-6-phosphatase, catalytic subunit,PIR_SUPERFAMILY[630001047$PIRSF000905:Glucose-6-phosphatase]
glucose-6-phosphatase, catalytic subunit,SMART[760000008$SM00014:acidPPc]
glucose-6-phosphatase, catalytic subunit,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000595$gluconeogenesis, 790000611$glycogen storage disease, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000922$membrane bound, 790001047$nuclear membrane, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001555$transmembrane, 790001556$transmembrane protein]
glucose-6-phosphatase, catalytic subunit,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850000555$binding site:Substrate, 850021450$chain:Glucose-6-phosphatase, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117653$short sequence motif:Prevents secretion from ER, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
glucose-fructose oxidoreductase domain containing 1,COG_ONTOLOGY[90000073$General function prediction only]
glucose-fructose oxidoreductase domain containing 1,INTERPRO[450000584$IPR000683:Oxidoreductase, N-terminal, 450003619$IPR004104:Oxidoreductase, C-terminal, 450014426$IPR016040:NAD(P)-binding domain]
glucose-fructose oxidoreductase domain containing 1,PIR_SUPERFAMILY[630004854$PIRSF004908:GFO/IDH/MocA oxidoreductases]
glucose-fructose oxidoreductase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001092$oxidoreductase, 790001363$Secreted, 790001405$signal]
glucose-fructose oxidoreductase domain containing 1,UP_SEQ_FEATURE[850021482$chain:Glucose-fructose oxidoreductase domain- containing protein 1, 850117814$signal peptide, 850118574$splice variant]
glutamate-rich 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
glutamate-rich 1,UP_SEQ_FEATURE[850021614$chain:Glutamate-rich protein 1, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
guanylate binding protein 4,INTERPRO[450002808$IPR003191:Guanylate-binding protein, C-terminal, 450014315$IPR015894:Guanylate-binding protein, N-terminal]
guanylate binding protein 4,PIR_SUPERFAMILY[630005479$PIRSF005552:guanine nucleotide-binding protein 1]
guanylate binding protein 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001212$polymorphism]
guanylate binding protein 4,UP_SEQ_FEATURE[850022800$chain:Guanylate-binding protein 4, 850102585$compositionally biased region:Poly-Val, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant]
headcase homolog (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790001162$phosphoprotein]
headcase homolog (Drosophila),UP_SEQ_FEATURE[850023018$chain:Headcase protein homolog, 850102390$compositionally biased region:Ala/Gly-rich, 850106258$modified residue]
